Vycor Medical (VYCO) EBT Margin Growth (3y) (2013 - 2026)
Vycor Medical (VYCO) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 329.00 |
| 10 | Vycor Medical | - | - | 375,153.00 | 229.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.00 |
| Dec 31, 2025 | 3,213.00 |
| Sep 30, 2025 | 3,720.00 |
| Jun 30, 2025 | 3,498.00 |
| Mar 31, 2025 | 1,469.00 |
| Dec 31, 2024 | -5,109.00 |
| Sep 30, 2024 | -1,760.00 |
| Jun 30, 2024 | -265.00 |
| Mar 31, 2024 | 6,897.00 |
| Dec 31, 2023 | -23,738.00 |
| Sep 30, 2023 | 6,334.00 |
| Jun 30, 2023 | 10,438.00 |
| Mar 31, 2023 | 5,213.00 |
| Dec 31, 2022 | 30,977.00 |
| Sep 30, 2022 | -9,294.00 |
| Jun 30, 2022 | -6,573.00 |
| Mar 31, 2022 | -7,493.00 |
| Dec 31, 2021 | 2,534.00 |
| Sep 30, 2021 | -3,105.00 |
| Jun 30, 2021 | -13,857.00 |